华北制药一季度归母净利润同比增216.7%至5749万元

财中社2025-04-23

4月23日，华北制药(600812)公布2025年一季报，公司营业收入为25.7亿元，同比上升0.7%；归母净利润为5749万元，同比上升216.7%；扣非归母净利润为5522万元，同比上升376.6%；经营现金流净额为1.63亿元，同比下降71.2%；EPS(全面摊薄)为0.0335元。截至一季度末，公司总资产219.94亿元，较上年度末增长2.4%；归母净资产为54.48亿元，较上年度末增长...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2529750626?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-23 19:01","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2529750626","market":"sh","top_or_hot":-1,"title":"华北制药一季度归母净利润同比增216.7%至5749万元","media":"财中社","content":"<div>\n<p>4月23日，华北制药(600812)公布2025年一季报，公司营业收入为25.7亿元，同比上升0.7%；归母净利润为5749万元，同比上升216.7%；扣非归母净利润为5522万元，同比上升376.6%；经营现金流净额为1.63亿元，同比下降71.2%；EPS(全面摊薄)为0.0335元。截至一季度末，公司总资产219.94亿元，较上年度末增长2.4%；归母净资产为54.48亿元，较上年度末增长...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042319021694df76ff&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>华北制药一季度归母净利润同比增216.7%至5749万元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n华北制药一季度归母净利润同比增216.7%至5749万元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-23 19:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042319021694df76ff&s=b><strong>财中社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>4月23日，华北制药(600812)公布2025年一季报，公司营业收入为25.7亿元，同比上升0.7%；归母净利润为5749万元，同比上升216.7%；扣非归母净利润为5522万元，同比上升376.6%；经营现金流净额为1.63亿元，同比下降71.2%；EPS(全面摊薄)为0.0335元。截至一季度末，公司总资产219.94亿元，较上年度末增长2.4%；归母净资产为54.48亿元，较上年度末增长...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042319021694df76ff&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"600812","symbol_name":"华北制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042319021694df76ff&s=b","article_id":"2529750626","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042319021694df76ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2529750626","pubTimestamp":1745406095,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"4月23日，华北制药公布2025年一季报，公司营业收入为25.7亿元，同比上升0.7%；归母净利润为5749万元，同比上升216.7%；扣非归母净利润为5522万元，同比上升376.6%；经营现金流净额为1.63亿元，同比下降71.2%；EPS为0.0335元。截至一季度末，公司总资产219.94亿元，较上年度末增长2.4%；归母净资产为54.48亿元，较上年度末增长1.1%。此外，公司的总资产在报告期末达到219.94亿元，表明其资产规模有所增长。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"600812":"华北制药"},"translate_title":"North China Pharmaceutical's net profit attributable to the parent company in the first quarter increased by 216.7% year-on-year to 57.49 million yuan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600812":1},"content_text":"4月23日，华北制药(600812)公布2025年一季报，公司营业收入为25.7亿元，同比上升0.7%；归母净利润为5749万元，同比上升216.7%；扣非归母净利润为5522万元，同比上升376.6%；经营现金流净额为1.63亿元，同比下降71.2%；EPS(全面摊薄)为0.0335元。截至一季度末，公司总资产219.94亿元，较上年度末增长2.4%；归母净资产为54.48亿元，较上年度末增长1.1%。公司在2025年第一季度的报告中显示，主要业务涵盖制药行业，产品包括各类药品的研发、生产和销售。公司致力于通过精益管理和全面预算控制来提升盈利能力，并降低采购成本和各项费用，从而实现业务的可持续发展。在股东信息方面，公司主要股东包括冀中能源股份有限公司和华北制药集团有限责任公司等，整体持股结构较为稳定。报告期内，公司的经营活动产生的现金流量净额为1.63亿元，显示出一定的资金流动性。此外，公司的总资产在报告期末达到219.94亿元，表明其资产规模有所增长。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2529750626","isCrawlerRequest":true}